Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AHPBA Pancreatic Irreversible Electroporation (IRE) Registry for Pancreatic Cancer

NCT02674100 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT02674100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02674100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AHPBA Pancreatic Irreversible Electroporation (IRE) Registry for Pancreatic Cancer
Lead sponsor
University of Louisville
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2016
Completion date
January 31, 2030
Enrollment
500 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer